Equifax drops as it holds 2026 outlook, flags mortgage slowdown after Iran conflict

EFXEFX

Equifax shares fell after the company said it is maintaining its full-year 2026 outlook despite a Q1 beat, citing reduced U.S. mortgage activity as rates rose following the Iran conflict. The stock is sliding as investors focus on macro uncertainty and the outlook for mortgage-driven revenue momentum.

1. What’s driving the move

Equifax (EFX) is lower today as investors digest its April 21, 2026 earnings release and guidance commentary. While the company posted a strong first quarter, it said it is maintaining its full-year 2026 constant-dollar revenue growth outlook because U.S. mortgage activity has fallen as rates moved higher since the Iran conflict and macro conditions remain uncertain. (sec.gov)

2. The numbers investors are reacting to

Equifax reported Q1 2026 revenue of $1.649 billion and adjusted EPS of $1.86, with management attributing the quarter’s outperformance to strong U.S. mortgage revenue growth earlier in the quarter before rates increased. In its outlook, Equifax guided Q2 adjusted EPS to $2.15–$2.25 and Q2 revenue to $1.68–$1.71 billion, and projected full-year adjusted EPS of $8.34–$8.74 on revenue of $6.685–$6.805 billion. (sec.gov)

3. Why the market is selling despite a beat

The key takeaway weighing on the shares is that Equifax did not translate the Q1 beat into a stronger full-year operating outlook, effectively signaling that the mortgage-driven upside seen early in the quarter may not persist. Equifax specifically pointed to a post-conflict rise in rates, weaker mortgage activity, and broader macro uncertainty as reasons to keep the annual view unchanged (aside from a modest FX-related lift to reported revenue and adjusted EPS). (sec.gov)

4. What to watch next

Investors will be watching whether mortgage volumes stabilize and whether Equifax’s mortgage-sensitive lines can hold up if rates stay elevated, since management tied Q1 strength to earlier-quarter mortgage activity and described subsequent conditions as more uncertain. Near-term, the next focal point is whether Q2 results track within the $1.68–$1.71 billion revenue range and $2.15–$2.25 adjusted EPS range, which would help validate the company’s maintained full-year framework. (sec.gov)